05376662 is referenced by 61 patents and cites 15 patents.

The specification discloses a method of treating a human or animal patient suffering from a pain syndrome secondary to nerve injury comprising daily administration to such patient of from about 0.4 milligrams to about 2.0 milligrams of the opiate-receptor antagonist naloxone for a treatment period of from around 3 months to around 12 months, depending upon the patient's needs. Delivery is preferably at or near the nerve injury site by a number of conventional injection methods.

Title
Method of attenuating nerve injury induced pain
Application Number
8/163930
Publication Number
5376662
Application Date
December 8, 1993
Publication Date
December 27, 1994
Inventor
David M Ockert
860 United Nations Plz., 20F, New York, 10017
NY, US
Agent
Price Heneveld Cooper DeWitt & Litton
IPC
A61K 31/485
View Original Source